Randomized phase II trial of carboplatin-paclitaxel compared to carboplatin-paclitaxel-trastuzumab in advanced or recurrent uterine serous carcinomas that overexpress Her2/Neu (NCT01367002)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Santin, AD; Fader, A; Roque, DM; Eric, S; Buza, N; Pei, H; Abdelghany, O; Chambers, SK; Secord, AA; Havrilesky, L; O'Malley, DM; Backes, F; Nevadunsky, N; Edraki, B; Pikaart, D; Lowery, W; ElSahwi, K; Celano, P; Bellone, S; Azodi, M; Litkouhi, B; Elena, R; Silasi, DA; Schwartz, P

Published Date

  • November 1, 2017

Published In

Volume / Issue

  • 27 /

Start / End Page

  • 15 - 16

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 1525-1438

International Standard Serial Number (ISSN)

  • 1048-891X